Research Article
Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients
Table 2
Changes in biochemical markers during the study period.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTx, cross-linked C-terminal telopeptide of type 1 collagen; 25(OH)D, 25-hydroxyvitamin D; ameasured 6 months after the total of 3 denosumab injections administered at 6-month intervals; bpercentage change of baseline versus 18 months; value by the one-way ANOVA and post-hoc analysis; Dunnett’s method was applied for the post-hoc analysis; compared with the baseline. |